Sodium-dependent Cl−/HCO3− exchange in patients with chronic renal failure: Correlation with renal function  by Tepel, Martin et al.
Sodium-dependent Cl2/HCO3
2 exchange in patients with chronic
renal failure: Correlation with renal function
MARTIN TEPEL, OLIVER NESBIT, FARUK TOKMAK, and WALTER ZIDEK
Universita¨tsklinik Marienhospital, Medizinische Klinik I, Ruhr-Universita¨t-Bochum, Herne, Germany
Sodium-dependent Cl2/HCO3
2 exchange in patients with chronic renal
failure: Correlation with renal function. To investigate the effects of
uremia on cellular function the activity of the sodium-dependent chloride-
bicarbonate exchanger (sodium-dependent Cl2/HCO3
2 exchanger) and
the sodium-independent chloride-bicarbonate exchanger (sodium-inde-
pendent Cl2/HCO3
2 exchanger) were examined in lymphocytes from 25
patients with mild chronic renal failure, 9 patients with end-stage chronic
renal failure on regular hemodialysis, and from 25 age-matched healthy
control subjects. Cytosolic pH (pHi) and the activity of the sodium-
dependent Cl2/HCO3
2 exchanger and the sodium-independent Cl2/
HCO3
2 exchanger were measured spectrophotometrically using the pH-
sensitive fluorescent dye 2979-bis-carboxyethyl-5 [6]-carboxyfluorescein
acetoxy-methylester (BCECF-AM). The activation of the sodium-depen-
dent Cl2/HCO3
2 exchanger by removal of extracellular chloride was
prevented in the presence of 500 mmol/liter 4,49 diisothiocyanostilbene-
2,29-disulfonic acid (DIDS) or in the absence of extracellular sodium, but
was not affected by the specific inhibitor of the sodium/proton exchanger,
ethyl isopropyl amiloride (EIPA). The sodium-dependent Cl2/HCO3
2
exchangers were significantly different in lymphocytes from healthy con-
trol subjects, patients with mild chronic renal failure, and patients with
end-stage chronic renal failure (X2 5 6.43, P 5 0.040 by Kruskal-Wallis-
test). The sodium-dependent Cl2/HCO3
2 exchanger was significantly
lower in patients with end-stage chronic renal failure compared to patients
with mild chronic renal failure or compared to healthy control subjects
(each P , 0.05). In patients with chronic renal failure a significantly
negative correlation between sodium-dependent Cl2/HCO3
2 exchanger
and the serum creatinine concentration (r 5 20.507; P 5 0.0022) could be
observed. On the other hand, resting pHi in lymphocytes and sodium-
independent Cl2/HCO3
2 exchanger were not significantly different in
lymphocytes from healthy control subjects, patients with mild chronic
renal failure or patients with end-stage chronic renal failure. The present
study suggests that the activity of the sodium-dependent Cl2/HCO3
2
exchanger is progressively impaired in chronic renal failure.
The activity of some ion transport systems present in blood cells
was measured to understand the consequences of the altered
metabolic profile of patients with chronic renal failure [1–3]. A
decreased Na1,K1-ATPase activity was repeatedly observed [1].
Altered cytosolic pH (pHi) regulation may be responsible for
vasconstriction and vascular hypertrophy in these patients [4, 5].
Previous investigations showed an increased activity of the sodi-
um-proton exchanger (Na1/H1 exchanger) in lymphocytes but
not in platelets from patients in chronic failure [3, 6]. Since that
transport system is related to cellular growth regulation, this
finding may not only be relevant for cellular pHi regulation, but
also for other pathologic consequences of chronic renal failure,
such as vascular hypertrophy and atherosclerosis. With respect to
intracellular pHi regulation, other ion transport systems may
contribute as well to cellular pHi homeostasis under the condi-
tions of increased acid load. Other mechanisms critically involved
in intracellular pHi regulation are the sodium-dependent chlo-
ride-bicarbonate anion exchanger (sodium-dependent Cl2/
HCO3
2 exchanger) and the sodium-independent chloride-bicar-
bonate anion exchanger (sodium-independent Cl2/HCO3
2
exchanger) [7, 8]. The sodium-dependent Cl2/HCO3
2 exchanger
defends the cell against acid loads. The sodium-dependent Cl2/
HCO3
2 exchanger extrudes chloride ions from the cells and
simultaneously takes up one HCO3
2 for each Cl2 ion, thereby
promoting intracellular alkalosis. In contrast, because the inward
gradient for chloride usually exceeds that for HCO3
2, the sodium-
independent Cl2/HCO3
2 exchanger catalyzes the net efflux of
HCO3
2, therefore acting as a cell acidifying mechanism. The
stimulation of the sodium-dependent Cl2/HCO3
2 exchanger is
one potential mechanism to compensate for intracllular acidosis.
An increased activity of the sodium-dependent Cl2/HCO3
2
exchanger has been described in erythrocytes from essential
hypertensive patients compared to normotensive control subjects
[9]. In addition, an increased activity of the sodium-independent
Cl2/HCO3
2 exchanger could be observed in erythrocytes from
essential hypertensive patients [10].
In renal insufficiency, acidosis has been shown to stimulate
another transport system regulating pHi, the sodium/proton ex-
changer activity. Therefore, it was tempting to examine whether
the Cl2/HCO3
2 exchangers might also be changed by the distur-
bances on acid-base metabolism associated with renal insuffi-
ciency.
In the present study the activity of the sodium-dependent
Cl2/HCO3
2 exchanger and the sodium-independent Cl2/HCO3
2
exchanger were examined in patients with chronic renal failure. In
these patients with chronic renal failure a significant correlation
between sodium-dependent Cl2/HCO3
2 exchanger and the se-
rum creatinine concentration could be observed.
METHODS
Subjects
Blood was obtained from 25 healthy control subjects (15 men,
10 women, mean age 47 6 4 years), 25 patients with mild chronic
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renal failure (14 men, 11 women, mean age 52 6 3 years), and 9
patients with end-stage chronic renal failure on regular hemodi-
alysis (6 men, 3 women, mean age 45 6 5). All subjects and
patients gave informed consent. The clinical and biochemical
characteristics of the patients and subjects are given in Table 1.
All patients with mild chronic renal failure or end-stage chronic
renal failure were recruited from among outpatients. Diagnosis of
chronic renal failure was based on serum creatinine concentration
elevated above 1.2 mg/dl. Chronic renal failure was due to chronic
glomerulonephritis (N 5 21), interstitial nephritis (N 5 10), and
polycystic kidney disease (N 5 3). Patients with diabetes mellitus
were excluded. As confirmed by the clinical examination, patients
were in a good state of health. No patient had significant pain,
elevated temperature, or other acute conditions. All patients were
stable, ambulatory, and free from intercurrent illness. Patients
with end-stage chronic renal failure on regular hemodialysis
performed three times weekly for four hours were free of inter-
current illness.
Healthy subjects with normal renal function were recruited in
the same manner from among outpatients with minor complaints
(such as skin rash, backache, etc.) to serve as controls. Subjects
with major medical illness and those who had taken prescription
medications were excluded. Serum creatinine, blood urea nitro-
gen, hemoglobin, and serum electrolyte concentrations were
analyzed by established laboratory methodology. In patients with
end-stage chronic renal failure blood was obtained before dialysis.
Preparation of lymphocytes
Lymphocytes were obtained according to established tech-
niques [11, 12]. Briefly, 20 ml heparinized blood was drawn by
venipuncture from the antecubital vein and centrifuged at 240 g
for 15 minutes. After removing the supernatant, lymphocytes were
isolated by layering 5 ml of diluted blood (1:1 vol:vol with isotonic
NaCl) on 3 ml of Lymphoprep (Nycomed, Uppsala, Sweden; 5.6%
wt/vol Ficoll; density, 1.077 g/ml) and centrifugation at 240 g for
20 minutes. The lymphocyte interphase was carefully aspirated,
washed three times in isotonic NaCl by centrifugation at 400 g for
five minutes, and resuspended in a HCO3
2/CO2 solution contain-
ing (in mmol/liter): NaCl, 112; KCl, 5.4; NaH2PO4, 0.23;
Na2HPO4, 0.97; CaCl2, 1.25; MgCl2, 1.25; D-glucose, 5.0; N-2-
hydroxyethylpiperazine-N9-2-ethanesulfonic acid, 5; NaHCO3,
22.0; pH 7.4. The solution was adjusted to pH 7.4 before the
addition of NaHCO3, and the mixture was then bubbled with 95%
O2—5% CO2 to maintain a pH of 7.4. The cell preparation
consisted of 22 6 1% monocytes and 78 6 1% lymphocytes (83 6
2% T lymphocytes and 17 6 6% B lymphocytes) as revealed by
FACScan (Becton Dickinson, Mountain View, CA, USA) using
fluorescein-isothiocyanate or phycoerythrine labeled monoclonal
antibodies (Dianova, Hamburg, Germany).
Measurements of cytosolic pH
Measurements of cytosolic pH (pHi) were done according to
established methodology using a pH sensitive fluorescent dye [6,
13, 14]. A stock solution of the pH sensitive fluorescent dye
2979-bis-carboxyethyl-5 [6]-carboxyfluorescein acetoxy-methyl-
ester (BCECF-AM; Sigma, Deisenhofen, Germany) at a final
concentration of 1 mmol/liter was prepared in dimethylsulfoxide.
The lymphocyte counts were adjusted to 106 cells/ml. The lym-
phocyte suspension (106 cells/ml) was incubated with 10 mmol/
liter of cell permeant BCECF-AM for 15 minutes at 37°C. After
centrifugation at 240 g for 15 minutes to remove extraneous dye,
the lymphocyte pellet was again resuspended in a HCO3
2/CO2
solution. This procedure efficiently removed the extraneous dye.
The leakage of dye during the experiment was less than 5% as
confirmed by fluorescence measurements of the supernatant after
centrifugation of the lymphocyte suspension. The fluorescence
intensity of a 1000 ml suspension of BCECF-loaded lymphocytes
was measured in a thermostated quartz cuvette with constant
stirring in a fluorescence spectrophotometer model F-2000 (Hi-
tachi Ltd, Tokyo, Japan) using the ROM Board (251-0250;
Hitachi Ltd.). The light source used was a 150-W xenon lamp with
ozone self-dissociation function. Monochromators were large
stigmatic concave gratings having 900 lines per millimeter used on
both excitation and emission sides. The wavelength drive motors
and slit control motors were operated by the computer. The
wavelength accuracy was better than 6 5 nm. Output signals from
the monitor detector and fluorescence detector (photomultiplier)
were processed via the A/D converter. Data sampling interval was
0.5 s with excitation wavelengths of 440 nm (representing the
isosbestic, pH-insensitive fluorescence excitation wavelength of
BCECF) and 495 nm (representing the pH sensitive fluorescence
excitation wavelength of BCECF; bandwidth, 10 nm), and the
emission wavelength was 530 nm (bandwidth, 10 nm). The
autofluorescence of lymphocytes was measured before addition of
the fluorescent dye and represented less than 1% of the fluores-
cence of BCECF-loaded lymphocytes.
At each lymphocyte preparation the fluorescence intensities
were converted to estimates of pHi using the high K
1/nigericin
method described by Thomas et al [15]. Briefly, lymphocytes were
resuspended in a buffer solution where NaCl has been replaced by
KCl (final concentration 141.4 mmol/liter) containing 5 mmol/liter
nigericin. The calibration was performed by sequential titrations
with 0.1 mol/liter potassium hydroxide while recording fluores-
cence intensity and extracellular pH. The fluorescence excitation
spectra and calibration curves are shown in Figure 1. As indicated
in the literature [6], the changes of lymphocytic pHi after the
Table 1. Clinical and biochemical characterization of healthy control
subjects (N 5 25), patients with mild chronic renal failure (N 5 25),
and patients with end-stage chronic renal failure on regular
hemodialysis (N 5 9)
Control
subjects
Patients with
mild chronic
renal failure
Patients with
end-stage
chronic renal
failure
P
value
Age years 47 6 4 52 6 3 45 6 5 NS
N male/female 15/10 14/11 6/3
Body mass index kg/m2 25 6 1 26 6 1 24 6 1 NS
Heart rate min21 75 6 1 75 6 1 80 6 3 NS
Blood pressure mm HG
Systolic 137 6 4 155 6 4 153 6 5 0.005
Diastolic 85 6 2 90 6 2 83 6 3 0.033
Creatinine mg/dl 0.9 6 0.1 2.0 6 0.3 7.4 6 0.8 , 0.001
Blood urea nitrogen
mg/dl
15 6 1 34 6 5 103 6 11 , 0.001
Hemoglobin g/dl 13.9 6 0.3 12.8 6 0.4 9.7 6 0.4 , 0.001
Serum potassium
mmol/liter
4.1 6 0.1 4.5 6 0.1 6.0 6 0.3 , 0.001
Serum calcium
mmol/liter
2.6 6 0.1 2.4 6 0.1 2.2 6 0.1 0.004
Values are mean 6 SEM. P values for these three groups were calculated
by Kruskal-Wallis test. NS denotes non-significant.
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addition of similar amounts of propionic acid are a reflection of
the cytosolic buffer capacity for H1. Intracellular buffer capacity
was measured as changes of pHi immediately after intracellular
acidification by 100 mmol/liter propionic acid.
Measurements of sodium-dependent Cl2/HCO3
2 exchange and
sodium-independent Cl2/HCO3
2 exchange
The activity of the sodium-dependent Cl2/HCO3
2 exchanger
was studied in experiments where Cl2 was removed from the
external media according to the procedure described earlier [7,
16, 17]. All experiments were conducted in the continuous pres-
ence of HCO3
2/CO2. The lymphocytic pHi was set to 7.2 using the
high K1/nigericin clamp technique. Lymphocytes were suspended
in KCl (final concentration 141.4 mmol/liter) buffer containing 5
mmol/liter nigericin. After incubating the lymphocytes in this
buffer for five minutes at 37°C, the intracellular pHi would be
equal to the extracellular pH. The lymphocytes were spun down
and washed with an identical KCl buffer at the same pH, but
which lacked nigericin and contained non-esterified fatty acid-free
bovine serum albumin (2 g/liter). This removed the ionophore and
kept the internal pHi clamped at the desired level [18]. Then, 100
ml of the lymphocyte suspension were added to 900 ml buffer
solution without Cl2 [19]. The composition of the buffer was
(mmol/liter): Na-aspartate, 112; K-aspartate, 5.4; NaH2PO4, 0.23;
Na2HPO4, 0.97; Ca-gluconate, 1.25; Mg-sulfate, 1.25; D-glucose,
5.0; N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic acid, 5;
NaHCO3, 22.0; pH 7.4. The pHi change produced by Cl
2 removal
was monitored fluorometrically as described above. The effects of
500 mmol/liter 4,49 diisothiocyanostilbene-2,29-disulfonic acid,
which is known to inhibit the Cl2/HCO3
2 exchange [8], were
investigated. The addition of 20 mmol/liter ethyl isopropyl amilo-
ride (EIPA; Biomol, Ko¨ln, Germany), which is known to specifi-
cally inhibit Na1/H1 exchange [6], did not prevent the intracel-
lular alkalinization after removal of chloride. In the absence of
extracellular sodium (replaced by choline) there was no significant
change of pHi after removal of extracellular chloride.
The activity of the sodium-independent Cl2/HCO3
2 exchange
was studied according to the procedure described earlier [7, 19].
In the presence of extracellular sodium, the lymphocytes were
alkalized by removal of external Cl2 as described above. Then, the
changes of lymphocytic pHi was monitored after readdition of
Cl2. The activity of the sodium-independent Cl2/HCO3
2 ex-
changer was taken as the difference in pHi observed under control
conditions (chloride-free control pHi recovery) and readdition of
Cl2 (chloride-induced pHi recovery).
Statistics
All data are presented as mean 6 SEM. Where error bars do not
appear on figures, errors are within the symbol size. Statistical
analysis was performed using the SPSS for Windows 5.01 software
package (SPSS Inc., Chicago, IL, USA). For statistical evaluation
of the data Kruskal-Wallis test was used and two-tailed P values
less than 0.05 were considered to be significant. Data were also
analyzed using analysis of variance with Newman-Keuls multiple
comparison test as indicated. The relation between selected
variables was tested by performing linear regression analysis.
RESULTS
Resting pHi was not significantly different in lymphocytes from
healthy control subjects (7.28 6 0.03; N 5 25), patients with mild
chronic renal failure (7.28 6 0.03, N 5 25), and patients with
end-stage chronic renal failure (7.20 6 0.05, N 5 9; x2 5 2.07, P 5
0.355 by Kruskal-Wallis test; Fig. 2). The intracellular buffer
capacity, measured by the use of propionic acid [6, 20–22], was
similar in lymphocytes from all groups (lymphocytes from healthy
control subjects, 0.75 6 0.03, N 5 25; patients with mild chronic
renal failure, 0.65 6 0.04, N 5 25; patients with end-stage chronic
renal failure, 0.77 6 0.05, N 5 9; x2 5 4.49, P 5 0.105 by
Kruskal-Wallis test).
The pHi changes produced by Cl
2 removal were monitored
spectrofluorometrically. A representative fluorescence tracing of
pHi changes after Cl
2 removal is shown in Figure 3. After
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Fig. 1. Original tracings showing the in situ
calibration of fluorescence measurements of
cytosolic pH (pHi) in lymphocytes.
Lymphocytes were loaded with the pH sensitive
fluorescent dye 2979-bis-carboxyethyl-5 [6]-
carboxyfluorescein acetoxy-methylester
(BCECF-AM) and suspended in a solution
containing 141.4 mmol/liter KCl and 5 mmol/
liter nigericin to equilibrate extracellular and
intracellular pH. The pH of the buffer solution
is given beside the tracings. The fluorescence
excitation bandwidth was 10 nm, and the
fluorescence emission was collected at 530 nm
with 10 nm bandwidth. The ratio of the
fluorescence intensity at 495 nm and 440 nm
excitaiton was calcuated. The calibration of the
F495/F440 fluorescence ratio in terms of pH is
shown as inset. Tracings representative of 59
similar experiments are shown.
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clamping the intracellular pHi to 7.2 using the high K
1/nigericin
clamp technique the removal of Cl2 produced a rapid increase of
pHi in the presence of extracellular sodium. The readdition of
chloride to lymphocytes with increased pHi after chloride removal
produced a pHi recovery from cell alkalinization (Fig. 3).
As shown in Figure 4, there was no significant change of pHi
after removal of extracellular chloride in the absence of extracel-
lular sodium (replaced by choline). In addition, no significant
alkalinization could be obtained in the presence of 500 mmol/liter
DIDS. The addition of DIDS significantly reduced the intracellu-
lar pHi increase after removal of extracellular chloride to 20.9 6
0.4% of the control value. These findings are consistent with the
activation of a sodium-dependent, DIDS-sensitive Cl2/HCO3
2
exchanger in lymphocytes [19].
After removal of Cl2 there was a rapid increase of pHi,
reaching a stable plateau after about one minute. The pHi
increase was 0.99 6 0.13 3 1023 pHi/second (N 5 25) in
lymphocytes from healthy control subjects, it was 1.01 6 0.13 3
1023 pHi/second (N 5 25) in lymphocytes from patients with mild
chronic renal failure (N 5 25), and it was 0.37 6 0.19 3 1023
pHi/second in lymphocytes from patients with end-stage chronic
renal failure (N 5 9; X2 5 6.43, P 5 0.040 by Kruskal-Wallis test;
P 5 0.035 by ANOVA; Fig. 5). The Newman-Keuls multiple
comparsion test showed a significant difference between the pHi
increase in lymphocytes from patients with end-stage chronic
renal failure compared to healthy control subjects (P , 0.05) or
compared to patients with mild chronic renal failure (P , 0.05).
Figure 5 shows that the changes of pHi values after removal of
extracellular Cl2 due to the activation of sodium-dependent
Cl2/HCO3
2 exchanger are scattered over a wide range in patients
with chronic renal failure. Since the extent of renal failure was
quite variable in this group, we examined whether renal function
was correlated to the sodium-dependent Cl2/HCO3
2 exchanger
activity. Analyzing the data from patients with chronic renal
failure showed a significant negative correlation between pHi
increase after removal of extracellular chloride and the serum
creatinine concentration (r 5 20.507; P 5 0.0022). That correla-
tion indicates that the activity of the sodium-dependent Cl2/
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Fig. 2. Scatter diagramm showing the resting cytosolic pH (pHi) in
lymphocytes from 25 healthy control subjects (E), 25 patients with mild
chronic renal failure (F), and 9 patients with end-stage chronic renal
failure (f). Resting pHi was measured spectrophotometrically using the
pH sensitive fluorescent dye 2979-bis-carboxyethyl-5 [6]-carboxyfluorescein
acetoxy-methylester (BCECF-AM) loaded into the lymphocytes. Mean
values are indicated. Resting pHi was not significantly different between
these groups as determined by Kruskal-Wallis test (x2 5 2.07, P 5 0.355).
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Fig. 3. Original tracing showing the intracellular alkalinization of lym-
phocytes after removal of extracellular Cl2 and the intracellular pH (pHi)
recovery from cell alkalinization after readdition of chloride. The changes
of pHi were monitored spectrophotometrically in lymphocytes loaded with
the pHi sensitive fluorescent dye 2979-bis-carboxyethyl-5 [6]-carboxyfluo-
rescein acetoxy-methylester (BCECF-AM). The lymphocytic pHi was set
to 7.2 using the high K1/nigericin clamp technique as described in the
Methods section. As indicated by the arrow the lymphocyte suspensions
were added to a sodium-containing buffer solution without Cl2, where
Cl2 had been replaced by aspartate, resulting in a rapid increase of pHi.
After reaching a plateau, the readdition of chloride–as indicated by the
arrow–produced a rapid pHi decrease.
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Fig. 4. Original tracings showing the intracellular alkalinization of
lymphocytes after removal of extracellular Cl2 (chloride-free). The
changes of intracellular pH (pHi) were monitored spectrophotometrically
in lymphocytes loaded with the pHi sensitive fluorescent dye 2979-bis-
carboxyethyl-5 [6]-carboxyfluorescein acetoxy-methylester (BCECF-AM).
The lymphocytic pHi was set to 7.2 using the high K
1/nigericin clamp
technique as described in the Methods section. As indicated by the arrow
the lymphocyte suspensions were added to a sodium-containing buffer
solution without Cl2 (chloride-free), where Cl2 had been replaced by
aspartate, a sodium-containing buffer solution without extracellular Cl2
but containing 500 mmol/liter 4,49 diisothiocyanostilbene-2,29-disulfonic
acid (DIDS), which is known to inhibit the Cl2/HCO3
2 exchange, a
sodium-containing buffer solution containing Cl2 (control) or a buffer
solution without extracellular Cl2 and without extracellular Na1 (sodium-
free). A significant increase of cytosolic pHi could be obtained by chloride
removal only in the presence of extracellular sodium (chloride-free) but
not in the absence of extracellular sodium (sodium-free). In the presence
of DIDS the pHi increase after removal of extracellular chloride was
significantly reduced. These findings are consistent with the activation of
a sodium-dependent, DIDS-sensitive Cl2/HCO3
2 exchanger in lympho-
cytes. Tracings are representative of 59 similar experiments. y 5 20.13x 1
1.28; r 5 20.507; P , 0.0022.
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HCO3
2 exchanger is progressively inhibited with decreasing renal
function (Fig. 6).
In the presence of extracellular sodium the removal of extra-
cellular chloride increased lymphocytic pHi by activation of the
sodium-dependent Cl2/HCO3
2 exchanger. Next, these cells were
used to investigate the activity of the sodium-independent Cl2/
HCO3
2 exchanger. The readdition of chloride to lymphocytes
with increased pHi after chloride removal produced a pHi recov-
ery from cell alkalinization due to the activation of the sodium-
independent Cl2/HCO3
2 exchanger. Typical original tracings are
shown in Figure 3 and Figure 7. In the presence of extracellular
sodium the exposure of lymphocytes to a chloride-free buffer
solution produced an intracellular alkalization reaching as stable
plateau after five minutes. Then, the chloride was added in order
to activate the sodium-independent Cl2/HCO3
2 exchanger. The
pHi decrease following the readdition of chloride was due to the
activation of the sodium-independent Cl2/HCO3
2 exchanger,
since additional experiments showed that the pHi decrease after
the readdition of chloride was similar in the absence and presence
of extracellular sodium (0.65 6 0.07 3 1023 pHi/second vs. 0.72 6
0.11 3 1023 pHi/second; N 5 5; P 5 0.69). The changes of pHi
after readdition of extracellular chloride were not significantly
different in lymphocytes from healthy control subjects (0.89 6
0.08 3 1023 pHi/second, N 5 25), patients with mild chronic renal
failure (0.97 6 0.07 3 1023 pHi/second, N 5 25), and from
patients with end-stage chronic renal failure (1.33 6 0.15 3 1023
pHi/second, N 5 9; X
2 5 4.55, P 5 0.103 by Kruskal-Wallis test;
Fig. 8). Using the data from patients with chronic renal failure, no
significant correlation between sodium-independent Cl2/HCO3
2
exchanger and the serum creatinine concentration could be
observed (P 5 0.163). The lymphocytes shown in Figure 7 were
centrifuged and resuspended again in KCl buffer at pH 7.2. Using
these lymphocytes the removal of Cl2 again produced a rapid
increase of pHi in the presence of extracellular sodium, indicating
that the effects observed were reversible.
DISCUSSION
This paper examines sodium-dependent Cl2/HCO3
2 exchanger
activity and sodium-independent Cl2/HCO3
2 exchanger activity
in lymphocytes from patients with mild chronic renal failure and
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Fig. 5. Scatter diagramm showing the sodium-dependent Cl2/HCO3
2
exchanger in lymphocytes from 25 healthy control subjects (E), 25
patients with mild chronic renal failure (F), and 9 patients with chronic
end-stage renal failure (f). The changes of intracellular pH were moni-
tored spectrophotometrically in lymphocytes loaded with the pH sensitive
fluorescent dye 2979-bis-carboxyethyl-5 [6]-carboxyfluorescein acetoxy-
methylester (BCECF-AM). The lymphocytic pHi was set to 7.2 using the
high K1/nigericin clamp technique as described in the Methods section.
The changes of pHi after removal of extracellular Cl
2 were determined.
The mean values are indicated. *P , 0.05 (Kruskal-Wallis test or analysis
of variance with Newman-Keuls multiple comparison test) compared to
healthy control subjects or to patients with mild chronic renal failure,
respectively.
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Fig. 6. Correlation between the changes of intracellular pH (pHi) due to
the activation of the sodium-dependent Cl2/HCO3
2 exchanger after
removal of extracellular Cl2 in lymphocytes from patients with chronic
renal failure and serum creatinine concentration. The changes of pHi
were monitored spectrophotometrically in lymphocytes from patients with
mild chronic renal failure (F) and from patients with end-stage chronic
renal failure (f) loaded with the pH sensitive fluorescent dye 2979-bis-
carboxyethyl-5 [6]-carboxyfluorescein acetoxy-methylester (BCECF-AM).
The lymphocytic pHi was set to 7.2 using the high K
1/nigericin clamp
technique as described in the Methods section. The changes of pHi after
removal of extracellular Cl2 were determined.
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Fig. 7. Original tracings showing the intracellular pH (pHi) recovery
from cell alkalinization after readdition of chloride due to to the
sodium-independent Cl2/HCO3
2 exchanger. The changes of intracellular
pHi were monitored spectrophotometrically in lymphocytes loaded with
the pHi sensitive fluorescent dye 2979-bis-carboxyethyl-5 [6]-carboxyfluo-
rescein acetoxy-methylester (BCECF-AM). After exposure of lympho-
cytes to a chloride-free buffer solution an intracellular alkalization was
observed. Then, the Cl2 was added as indicated by the arrow. The activity
of the sodium-independent Cl2/HCO3
2 exchanger was taken as the
difference in pHi observed under control conditions (control, for example,
chloride-free control pHi recovery) and readdition of Cl
2 (chloride, such
as chloride-induced pHi recovery). Tracings are representative of 59
similar experiments.
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patients with end-stage chronic renal failure. The present results
document that changes in sodium-dependent Cl2/HCO3
2 ex-
changer activity occur in the course of progressive renal failure.
After removal of extracellular chloride the pHi increased signifi-
cantly. In the absence of extracellular sodium the pHi increase
after chloride removal was significantly smaller. In the presence of
DIDS the pHi increase after chloride removal is significantly
reduced. This behavior is best explained assuming that chloride
removal activates the sodium-dependent Cl2/HCO3
2 exchanger.
That view is compatible with the findings in the literature [7, 16,
19]. Since extracellular sodium influenced the effects of chloride
removal on pHi increase, it is unlikely that the putative inhibition
of the sodium-independent Cl2/HCO3
2 exchanger after chloride
removal might be responsible for the pHi increase. The activity of
the sodium-dependent Cl2/HCO3
2 exchanger in lymphocytes
from healthy control subjects was similar to that described in
lymphocytes from rats by Batlle et al [7, 19]. With decreasing renal
function, the activity of the sodium-dependent Cl2/HCO3
2 ex-
changer decreases. Indeed, a significant negative correlation
between the activity of the sodium-dependent Cl2/HCO3
2 ex-
changer and serum creatinine could be observed. It is open to
debate whether there is a direct causal relationship between
glomerular filtration rate and the activity of the sodium-depen-
dent Cl2/HCO3
2 exchanger. Obviously, a uremic toxin accumu-
lating in renal failure could inhibit the sodium-dependent Cl2/
HCO3
2 exchanger. It is speculated that changes of the lipid
metabolism may be involved in that process, since the effects of
different lipoproteins on cellular ion transport systems have been
described recently [23, 24]. In addition, with decreasing renal
function other changes in electrolyte metabolism might occur,
which in turn could influence the sodium-dependent Cl2/HCO3
2
exchanger.
Resting pHi was not significantly changed in patients with
chronic renal failure, and therefore the present results allow the
speculation that the relative contribution of the transport systems
eliminating cellular acid change with decreasing renal function. It
has been repeatedly shown by our and other groups that another
important cellular ion transport system regulating intracellular
pHi, the Na
1/H1 exchanger, is stimulated in patients with chronic
renal failure [6, 20, 22]. It is speculated that the impaired activity
of the sodium-dependent Cl2/HCO3
2 exchanger is compensated
by an increased Na1/H1 exchanger activity. Obviously, the net
acid excretion from the cells is largely maintained with progressive
renal failure, as resting pHi values do not change significantly.
Whereas the sodium-dependent Cl2/HCO3
2 exchanger activity
is significantly inhibited in patients with chronic renal failure, the
sodium-independent Cl2/HCO3
2 exchanger activity is essentially
unaffected by renal function. A decreased net acid elimination by
a decreased HCO3
2 outward transport apparently does not
contribute to the compensatory changes maintaining cellular pHi
homeostasis. A schematic presentation of the involved transport
systems is given in Figure 9.
Taken together, the present results suggest the following
changes in cellular pH regulation with decreasing renal function:
The sodium-dependent Cl2/HCO3
2 exchanger activity is inhib-
ited with decreasing renal function. The intracellular acid accu-
mulation is prevented by an increased activity of the Na1/H1
exchanger [6, 20, 22]. The second potential way of compensation,
a decreased activity of the sodium-independent Cl2/HCO3
2
exchanger, does not contribute significantly to cellular pHi ho-
meostasis.
Reprint requests to Dr. Martin Tepel, Medizinische Klinik I, Universita¨-
tsklinik Marienhospital, Ruhr-Universita¨t-Bochum, Ho¨lkeskampring 40, D-
44625 Herne, Germany.
APPENDIX
Abbreviations used in this article are: BCECF-AM, 2979-bis-carboxy-
ethyl-5 [6]-carboxyfluorescein acetoxy-methylester; x2, chi squared; Cl2/
HCO3
2 exchanger, chloride-bicarbonate exchanger; DIDS, 4,49 diisothio-
cyanostilbene-2,29-disulfonic acid; EIPA, ethyl isopropyl amiloride; Na1/
H1, sodium proton exchanger; pHi, cytosolic pH.
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